Tango Therapeutics discloses $257.9M cash as of Dec 31, 2024

Tango Therapeutics, Inc.

Cash, cash equivalents and marketable securities totaled $257.9M (unaudited).
Company updated its corporate presentation for use with investors and analysts.
No other financial results or guidance were provided in this filing.

item 2.02 item 7.01 item 9.01

Tango Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-004977

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.